文献速递前列腺癌

男性对前列腺特异性抗原、磁共振成像及前列腺活检在前列腺癌筛查中的接受度

Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
PubMed 文献 · Eur Urol Oncol · 2023-11-22

基于人群随机筛选试验GÖTEBORG-2,邀请逾37 000名男性接受前列腺特异性抗原(PSA)检测,PSA升高者行磁共振成像(MRI),有指征者行前列腺活检。MRI依从性96%(1790/1872),活检依从性89%(810/907),问卷应答率75%(608/810)。完成全部检查的577名男性中,活检不适感高于PSA检测(p < 0.001)和MRI(p < 0.001);大多数男性仍愿意必要时重复所有检查。

要点

  • MRI依从性96%(1790/1872),活检依从性89%(810/907),问卷应答率75%(608/810)。
  • 完成全部检查者中,活检不适感高于PSA检测(p < 0.001)和MRI(p < 0.001)。
  • 高不适水平(≥4/5)比例:PSA检测2%(12/577)、MRI 8%(46/577)、活检43%(247/577)。

核心结论

  • 活检比MRI更令人不适,但绝大多数男性接受必要时重复这两项检查。
  • 对MRI阴性男性省略活检并转为仅靶向活检将减少参与前列腺癌筛查男性的不适。

研究设计与样本

  • 基于人群的随机GÖTEBORG-2前列腺癌筛查试验,邀请逾37 000名男性接受PSA检测,PSA升高者行MRI,有指征者行前列腺活检(靶向和/或系统活检)。
  • 参与者填写问卷,以1至5级分类量表(1=完全不困扰,5=非常困扰)评估每项检查(PSA、MRI、前列腺活检)的不适程度,并以0至10连续量表(0=是,毫不犹豫;10=不,绝对不愿意)标记重复检查的意愿,采用Wilcoxon符号秩检验。

主要发现

  • MRI依从性为96%(1790/1872),活检依从性为89%(810/907),问卷应答率为75%(608/810)。
  • 完成全部检查的男性(n = 577)报告活检比PSA检测更令人不适(p < 0.001),也比MRI更令人不适(p < 0.001)。
  • 高不适水平(≥4/5)报告率:PSA检测2%(12/577),MRI 8%(46/577),活检43%(247/577)。
  • 男性重复MRI的意愿高于重复活检(p < 0.001),但差异较小(中位数0.2[四分位距0.1-0.6] vs 0.5[0.1-2.0])。

临床怎么用

  • 对MRI阴性男性省略活检并转为仅靶向活检将减少参与前列腺癌筛查男性的不适。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A prerequisite before introducing a screening program is that the screening examinations are acceptable to participants. OBJECTIVE: To evaluate the acceptance and bother of prostate cancer screening examinations. DESIGN, SETTING, AND PARTICIPANTS: The randomized population-based GÖTEBORG-2 prostate cancer screening trial invited >37 000 men for prostate-specific antigen (PSA) testing followed by magnetic resonance imaging (MRI) in case of elevated PSA and prostate biopsy (targeted and/or systematic) if indicated. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Participants were asked to fill out a questionnaire and rate the level of bother associated with each examination (PSA, MRI, and prostate biopsy) on a categorical scale ranging from 1 to 5 (1 = "not at all bothersome" and 5 = "very bothersome"), and to rate their willingness to repeat the examinations, by marking an X on a continuous scale ranging from 0 to 10 (0 = "yes, without any hesitation" and 10 = "no, absolutely not"). Wilcoxon signed rank test was used. RESULTS AND LIMITATIONS: Compliance with MRI was 96% (1790/1872), compliance with biopsy was 89% (810/907), and the response rate to the questionnaire was 75% (608/810). Men who underwent all examinations (n = 577) responded that biopsy was more bothersome than PSA test (p < 0.001) and MRI (p < 0.001). High levels of bother (≥4 out of 5) were reported by 2% (12/577) for PSA test, 8% (46/577) for MRI, and 43% (247/577) for biopsy. Men were more willing to repeat MRI than biopsy (p < 0.001), but the difference was small (median 0.2 [interquartile range 0.1-0.6] vs 0.5 [0.1-2.0]). CONCLUSIONS: Biopsies are more bothersome than MRI, but a large majority of men accept to repeat both examinations if necessary. Omitting biopsy for MRI-negative men and shifting to targeted biopsies only will reduce bother for men participating in prostate cancer screening. PATIENT SUMMARY: We asked men how bothersome they found the prostate-specific antigen (PSA) test, magnetic resonance imaging (MRI), and prostate biopsies. Biopsies were more bothersome than PSA and MRI, but most men were willing to repeat all procedures if necessary.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Godtman RA, Pettersson C, Svensson L, et al. Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy. Eur Urol Oncol. 2023. PMID: 37993370. doi:10.1016/j.euo.2023.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。